| abstract |
compositions comprising sphingosine-1-phosphate (s1p) receptor modulators. the present invention relates to stable compositions comprising a sphingosine-1-phosphate (s1p) receptor modulator, suitable for use as a dosage form. s 1p receptor modulators are typically sphingosine analogs, such as 2-substituted 2-aminopropane-1,3-diol or 2-aminopropanol derivatives, for example, a compound comprising a group of formula y. |